Tae Min Kim, Jin Chul Paeng, In Kook Chun, Bhumsuk Keam, Yoon Kyung Jeon, Se-Hoon Lee, Dong-Wan Kim, Dong Soo Lee, Chul Woo Kim, June-Key Chung, Il Han Kim and Dae Seog Heo Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma Cancer 119
Article first published online: 4 DEC 2012 | DOI: 10.1002/cncr.27855
Metabolic tumor burden expressed as total lesion glycolysis in positron emission tomography is predictive of survivals in patients with diffuse large B cell lymphoma (DLBCL) who received rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) chemotherapy. Assessment of pretreatment total lesion glycolysis will be helpful to identify risk subgroups and design treatment plans in patients with DLBCL.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field